Methylprednisolone added to tocilizumab reduces mortality in SARS-CoV-2 pneumonia: An observational study.
Francisco SanzF Puchades GimenoP Ortega GarcíaC Ferrer GómezM D Ocete MochónM García DeltoroPublished in: Journal of internal medicine (2020)
Keyphrases
- sars cov
- rheumatoid arthritis
- cardiovascular events
- respiratory syndrome coronavirus
- high dose
- juvenile idiopathic arthritis
- rheumatoid arthritis patients
- risk factors
- respiratory failure
- cardiovascular disease
- type diabetes
- disease activity
- intensive care unit
- low dose
- systemic lupus erythematosus
- acute respiratory distress syndrome
- extracorporeal membrane oxygenation